|
bioMérieux S.A. (BIM.PA) DCF Valuation
FR | Healthcare | Medical - Diagnostics & Research | EURONEXT
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
bioMérieux S.A. (BIM.PA) Bundle
Explore bioMérieux S.A.'s (BIMPA) financial outlook with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate bioMérieux S.A.'s (BIMPA) intrinsic value and enhance your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,674.8 | 3,118.2 | 3,376.2 | 3,589.1 | 3,674.7 | 3,982.8 | 4,316.8 | 4,678.8 | 5,071.1 | 5,496.4 |
| Revenue Growth, % | 0 | 16.58 | 8.27 | 6.31 | 2.38 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 |
| EBITDA | 548.2 | 747.7 | 977.8 | 811.9 | 700.8 | 917.1 | 994.0 | 1,077.3 | 1,167.7 | 1,265.6 |
| EBITDA, % | 20.49 | 23.98 | 28.96 | 22.62 | 19.07 | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 |
| Depreciation | 207.5 | 228.4 | 220.4 | 257.6 | 259.4 | 285.5 | 309.5 | 335.4 | 363.6 | 394.1 |
| Depreciation, % | 7.76 | 7.32 | 6.53 | 7.18 | 7.06 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
| EBIT | 340.7 | 519.3 | 757.4 | 554.3 | 441.4 | 631.5 | 684.5 | 741.9 | 804.1 | 871.5 |
| EBIT, % | 12.74 | 16.65 | 22.43 | 15.44 | 12.01 | 15.86 | 15.86 | 15.86 | 15.86 | 15.86 |
| Total Cash | 275.0 | 389.2 | 803.5 | 552.6 | 352.4 | 569.9 | 617.7 | 669.5 | 725.7 | 786.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 647.3 | 689.5 | 709.0 | 865.2 | .0 | 728.2 | 789.3 | 855.5 | 927.2 | 1,004.9 |
| Account Receivables, % | 24.2 | 22.11 | 21 | 24.11 | 0 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 |
| Inventories | 501.3 | 562.2 | 648.2 | 767.5 | 908.5 | 813.1 | 881.3 | 955.2 | 1,035.3 | 1,122.1 |
| Inventories, % | 18.74 | 18.03 | 19.2 | 21.38 | 24.72 | 20.42 | 20.42 | 20.42 | 20.42 | 20.42 |
| Accounts Payable | 211.9 | 207.1 | 239.5 | 269.4 | 265.1 | 289.8 | 314.1 | 340.4 | 369.0 | 399.9 |
| Accounts Payable, % | 7.92 | 6.64 | 7.09 | 7.51 | 7.21 | 7.28 | 7.28 | 7.28 | 7.28 | 7.28 |
| Capital Expenditure | -272.5 | -277.5 | -290.1 | -286.7 | -338.3 | -357.5 | -387.4 | -419.9 | -455.1 | -493.3 |
| Capital Expenditure, % | -10.19 | -8.9 | -8.59 | -7.99 | -9.21 | -8.97 | -8.97 | -8.97 | -8.97 | -8.97 |
| Tax Rate, % | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 | 18.26 |
| EBITAT | 291.7 | 424.8 | 608.4 | 455.8 | 360.8 | 520.0 | 563.6 | 610.9 | 662.1 | 717.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -710.0 | 267.8 | 465.6 | 181.1 | 1,001.8 | -160.0 | 380.7 | 412.7 | 447.3 | 484.8 |
| WACC, % | 5.58 | 5.58 | 5.57 | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 | 5.58 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,270.1 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 499 | |||||||||
| Terminal Value | 19,368 | |||||||||
| Present Terminal Value | 14,764 | |||||||||
| Enterprise Value | 16,035 | |||||||||
| Net Debt | 166 | |||||||||
| Equity Value | 15,868 | |||||||||
| Diluted Shares Outstanding, MM | 119 | |||||||||
| Equity Value Per Share | 133.57 |
Benefits You Will Receive
- Customizable Excel Template: A dynamic Excel-based DCF Calculator featuring pre-populated financial data for bioMérieux S.A. (BIMPA).
- Accurate Data: Historical performance metrics and future projections (highlighted in the yellow cells).
- Assumption Flexibility: Adjust key forecast variables such as revenue growth, EBITDA percentage, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of bioMérieux S.A. (BIMPA).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for simplicity and ease of navigation, complete with step-by-step guidance.
Key Features
- Customizable Forecast Inputs: Adjust essential variables such as sales growth, EBITDA percentage, and capital expenditures.
- Instant DCF Valuation: Quickly determines intrinsic value, NPV, and additional metrics.
- High-Precision Outcomes: Leverages bioMérieux's real-world financial data for accurate valuation results.
- Effortless Scenario Analysis: Evaluate various assumptions and compare results with ease.
- Time-Efficient Solution: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Operates
- Download: Get the pre-prepared Excel file containing bioMérieux S.A.’s (BIMPA) financial metrics.
- Customize: Tailor your forecasts by adjusting revenue growth, EBITDA %, and WACC.
- Update Automatically: Enjoy real-time updates for intrinsic value and NPV calculations.
- Test Scenarios: Generate various projections and instantly analyze different outcomes.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Opt for This Calculator for bioMérieux S.A. (BIMPA)?
- All-in-One Tool: Combines DCF, WACC, and financial ratio analyses seamlessly.
- Flexible Settings: Modify yellow-highlighted fields to explore different scenarios.
- In-Depth Analysis: Instantly computes bioMérieux's intrinsic value and Net Present Value.
- Pre-Loaded Metrics: Access historical and projected data for precise calculations.
- Expert Grade: Perfect for financial analysts, investors, and business consultants.
Who Should Utilize bioMérieux S.A. (BIMPA)?
- Healthcare Professionals: Enhance patient care decisions with advanced diagnostics tools.
- Clinical Researchers: Streamline research processes with reliable assay solutions tailored for various applications.
- Laboratory Managers: Optimize workflow efficiency by integrating innovative technology into laboratory operations.
- Public Health Officials: Utilize real-time data to improve health outcomes and disease response strategies.
- Students and Educators: Explore hands-on learning opportunities in microbiology and diagnostics through practical resources.
Contents of the Template
- Historical Data: Contains bioMérieux S.A.’s (BIMPA) previous financial records and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for calculating the intrinsic value of bioMérieux S.A. (BIMPA).
- WACC Sheet: Pre-configured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust key parameters such as growth rates, EBITDA percentages, and CAPEX estimates.
- Quarterly and Annual Statements: A thorough analysis of bioMérieux S.A.’s (BIMPA) financial performance.
- Interactive Dashboard: Dynamically visualize valuation results and future projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.